The Pharmacokinetics of Mirtazapine in Cats with Chronic Kidney Disease and In Age-Matched Control Cats

Journal of Veterinary Internal Medicine

Volumn 25, Issue 5, 2011, Pages 985-989

  Quimby, J M ^a   Gustafson, D L ^a   Lunn, K F ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Appetite; Feline; Nutrition; Renal

Indexed keywords

APPETITE STIMULANT; CREATININE; DRUG DERIVATIVE; MIANSERIN; MIRTAZAPINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; FEMALE; HALF LIFE TIME; MALE; METABOLISM;

ANIMALS; APPETITE STIMULANTS; CAT DISEASES; CATS; CREATININE; FEMALE; HALF-LIFE; KIDNEY FAILURE, CHRONIC; MALE; MIANSERIN;

ANIMALIA; FELIDAE;

EID: 80053089522     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00780.x     Document Type: Article

References (14)

1. Goldstein RE, Marks SL, Kass PH, et al. Gastrin concentrations in plasma of cats with chronic renal failure. J Am Vet Med Assoc 1998;213:826-828.
2. Plotnick A. Feline chronic renal failure: Long-term medical management. Compend Contin Educ Vet 2007;29:342-344.
3. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: Effect of dietary management. J Small Anim Pract 2000;41:235-242.
4. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006;229:949-957.
5. Plantinga EA, Everts H, Kastelein AM, et al. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 2005;157:185-187.
6. Kast RE, Foley KF. Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. Eur J Cancer Care (Engl) 2007;16:351-354.
7. Pae CU. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1143-1145.
8. Timmer CJ, Sitsen JM, Delbressine LP. Clinical pharmacokinetics of mirtazapine. Clin Pharmacokinet 2000;38:461-474.
9. Quimby JM, Gustafson DL, Samber BJ, et al. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats. J Vet Pharmacol Ther 2011;34:388-396. doi: 101111/j1365-2885201001244x.
10. Cahill C. Mirtazapine as an antiemetic. Veterinary Forum 2006:34-36.
11. Polzin DJ, Osborne CA, Ross SJ. Chronic kidney disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: WB Saunders; 2005:1756-1785.
12. Wagner J. Pharmacokinetics for the Pharmaceutical Scientist. Lancaster, PA: Technomic Publishing Company, Inc; 1993.
13. Bengtsson F, Hoglund P, Timmer CJ, et al. Mirtazapine oral single dose kinetics in patients with different degrees of renal failure. Human Psychopharmacolog 1998;13:357-365.
14. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008;3:348-354.